hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-04-26吡仑帕奈特别设计用药可改善部分发作型癫痫患者的症状
- 2022-04-25多一动还是顽皮?多一动症儿童有哪些表现?家长们要分清啦!
- 2022-04-21全面性癫痫的先兆研究课题
- 2022-04-13罕见病例:自发性颞极性扩张伴癫痫发作
- 2022-04-11第四届全国临床脑电图实践基础理论与实践操作培训班
- 2022-04-072013国际抗癫痫联合会抗癫痫药用指南
- 综述:癫痫持续状态诊治最新进展
- 第四届全国临床脑电图实践基础理论与实践操作培训班
- FDA批准Aptiom用于治疗患者癫痫发作
- 2013国际抗癫痫联合会抗癫痫药用指南
- 月经性癫痫患者妊娠期癫痫控制更好
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 控制癫痫患者再次抽搐,不包括可选药物?
- 癫痫治疗障碍仍难以克服
- 继发性癫痫能治愈吗 治疗癫痫有几个步骤
- 三庚酸酯可治疗1型转运体缺陷综合征
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 癫痫症状 如何护理癫痫患者?
- 月经期间要注意 有些药物和食物不能食用
- 睡觉时突然抽搐 新生儿睡觉抽搐怎么办?
- 38癫痫患者年病史上的感谢信 道出了浓浓的医患情况
- 2016AAN:神经专家发表了有前途的专业见解
- 预测癫痫患者再入院风险
- 羊角病能生孩子吗?
- 如何治疗女性癫痫?
- 2015 神经系统疾病诊疗进展
- 2015第31届国际癫痫大会(IEC)
- 被WHO推荐,IVD国产替代品在结核病诊断领域取得了新的成果
- 抗癫痫药物预防新发癫痫:任重而道远
- 癫痫猝死:凶手是谁?
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- FDA警告怀孕期间使用丙戊酸钠药物
- NeuroImage:纤维球成像可用于癫痫的进展
- 北京癫痫病专科医院化疗费用
- 疗程癫痫病方法那个好
- 青少年癫痫病怎么治疗最完全
- 抗击癫痫在中国:20年征程,从临床走向公卫战略目标
- 癫痫病的检验要了解什么症状
- 癫痫的治疗方式 中医拔罐治癫痫小方式(2)
- 抑郁症的病因有什么
- 治愈儿童癫痫病都是需要多少费用
- 癫痫病是什么原因转变成的
- 癫痫病能治愈吗,先为详细了解情况?
- 本品难治性癫痫患者的神经调控治疗
- 癫痫病需要怎样来进行病患
- 20130508养生堂:栾国明讲癫痫病的以前症状